Vol. 10 No. 1 (2003)

DOI: https://doi.org/10.5912/jcb.v10i1

Published: 2003-09-01

Editorial

Editorial: Creating a competitive European life science sector

Jane Fisken
- PDF
Financing papers: The role of the European Commission in fostering innovation in the life sciences and biotechnology

Waldemar KÃ¼tt, Etienne Magnien, Mark Cantley
- PDF

Article

Commercial biotechnology in Germany: An overview

Siegfried Bialojan, Julia SchÃ¼ler
- PDF
What will it take to get institutional investors interested in life sciences again?

William Brooks
- PDF
Consolidation challenges in Europe's life science sector â€“ Making it happen

Wolfgang Stoiber
- PDF
Riposte: FDA response to 'Yin, yang and the biopharmaceutical industry'

Amy S Rosenberg, Karen D Weiss, Michael Lanthier, Roger Eastep, William Egan, Jesse L Goodman, Janet Woodcock
- PDF
The Sarbanesâ€“Oxley Act and non-US issuers: Considerations for international companies

Megan N Gates
- PDF
Biotechnology and pharmaceutical R&D and licensing trends: You pays your money and takes your chances

Alan Ratliff
- PDF
The impact of pharmacogenetics and pharmacogenomics

Klaus Lindpaintner
- PDF
A new model to evaluate the market for biotechnology

Amanda McMurray, Richard Jones
- PDF
Biotechnology M&A insight: Deals and strategies

Alex K Pavlou
- PDF
Additional on-line material: Pharmacoeconomics and the growth of the biotechnology industry

Thomas D Szucs, Sebastian Schneeweiss
- PDF

Legal and Regulatory Updates

Legal and regulatory update

John Wilkinson
- PDF
Financial accounts reports

David Citron
- PDF

Book Review

Book Review: Biotech Alliances: Bridging the R&D Gap

Nerida Scott
- PDF